![]() |
Volumn 376, Issue 17, 2017, Pages 1690-1692
|
Spironolactone metabolites in TOPCAT - New insights into regional variation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CANRENONE;
DRUG METABOLITE;
PLACEBO;
SPIRONOLACTONE;
MINERALOCORTICOID ANTAGONIST;
ALDOSTERONE BLOOD LEVEL;
CANADA;
CONTROLLED STUDY;
CORRELATIONAL STUDY;
DRUG RESPONSE;
DRUG USE;
HEART FAILURE WITH PRESERVED EJECTION FRACTION;
HOSPITALIZATION;
HUMAN;
INCIDENCE;
LETTER;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY (TOPIC);
POTASSIUM BLOOD LEVEL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
REGIONALIZATION;
RUSSIAN FEDERATION;
UNITED STATES;
BLOOD;
CLINICAL TRIAL (TOPIC);
COMPARATIVE STUDY;
HEART FAILURE;
MEDICATION COMPLIANCE;
METABOLISM;
CANADA;
CANRENONE;
CLINICAL TRIALS AS TOPIC;
HEART FAILURE;
HUMANS;
MEDICATION ADHERENCE;
MINERALOCORTICOID RECEPTOR ANTAGONISTS;
RUSSIA;
SPIRONOLACTONE;
UNITED STATES;
|
EID: 85018939774
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc1612601 Document Type: Letter |
Times cited : (193)
|
References (5)
|